Clinical Trials

Adrenocortical Carcinoma

NCT07306325 2025-12-29

Ultrasound in Predicting Difficult Intubation in Acromegaly Patients

Not yet recruiting

34 enrolled

Phase 2 Enrolling by invitation

Acromegaly, Growth Hormone-Secreting Pituitary Adenoma

NCT07121478 2025-10-01

Patients With High-grade Pancreatic Neuroendocrine Tumors

46 enrolled

Adenoma, Islet Cell, Neuroendocrine Tumors

NCT07185672 2025-09-22

PReCedeNT

Phase 3 Recruiting

162 enrolled

Neuroendocrine Tumors

NCT06261190 2025-05-11

MAeSTro-EXP

Enrolling by invitation

499 enrolled

Phase NA Not yet recruiting

Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT06730893 2025-04-30

MAeSTro-SDM

310 enrolled

Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT06725628 2024-12-10

Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid Carcinoma

Not yet recruiting

2,000 enrolled

Thyroid Cancer, Papillary

NCT06626581 2024-10-04

Iodine Status and Characteristics of Papillary Thyroid Cancer

Not yet recruiting

600 enrolled

Thyroid Cancer, Papillary

NCT06399159 2024-05-22

Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images

1,500 enrolled

Thyroid Cancer, Papillary, Lymphatic Metastasis

NCT06330558 2024-03-28

Side-specific Factors for Conversion in Adrenalectomy for Pheochromocytoma.

271 enrolled

EndocrineNETOther solid neoplasmThoracic

Adrenal Gland Neoplasms

NCT04375267 2023-11-14

LuPARP

Phase 1 Unknown

18 enrolled

Mesothelioma, Thymoma, Neuroendocrine Tumors

NCT05873283 2023-05-24

Papillary Thyroid Cancer and Central Lymp Node Dissection

250 enrolled

Thyroid Cancer, Papillary

NCT05451134 2022-07-12

Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma

300 enrolled

Paraganglioma, Pheochromocytoma

NCT04021212 2022-05-11

Pituitary Adenoma and Serum Lipid

1,000 enrolled

Pituitary Diseases, Pituitary Neoplasms, Recurrence

NCT05082311 2022-02-10

PheoCard

55 enrolled

Cardiomyopathies, Paraganglioma, Pheochromocytoma

NCT01774279 2021-01-05

iNATT

350 enrolled

Thyroid Carcinoma, Anaplastic

NCT04622631 2020-11-10

Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT

80 enrolled

Neuroendocrine Tumors

NCT04500925 2020-08-05

The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience

301 enrolled

Thyroid Cancer, Papillary

NCT04424485 2020-06-11

Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy

Thyroid Cancer, Papillary, Lymphatic Metastasis, Thyroid Neoplasms

NCT04411290 2020-06-02

Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases

EndocrineHead & NeckLymphoid

200 enrolled

Euthyroid Goiter, Thyroid Cancer, Papillary, Burkitt Lymphoma, Goiter, Thyroid Diseases, Thyroid Neoplasms, Thyroid Nodule

NCT04396912 2020-05-21

Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort

Thyroid Cancer, Papillary, Thyroid Neoplasms, Vocal Cord Paralysis, Wounds and Injuries, Thyroid Nodule

NCT03840720 2020-04-28

The Patient's Journey - the Time to Final Diagnosis in Patients With SiNET

20 enrolled

Neuroendocrine Tumors

NCT04336696 2020-04-07

Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0?

199 enrolled

Thyroid Cancer, Papillary, Carcinoma, Papillary

NCT02125474 2019-11-14

Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate

Phase NA Completed

39 enrolled

Neuroendocrine Tumors

NCT04152928 2019-11-06

Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities

50 enrolled

Neuroendocrine Tumors

NCT04154241 2019-11-06

Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor

50 enrolled

EndocrineGastrointestinalNET

Neuroendocrine Tumors

NCT03963193 2019-05-24

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

Phase 2 Unknown

112 enrolled

Gastro-enteropancreatic neuroendocrine tumor

NCT03083834 2019-01-18

Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients

50 enrolled

Adrenal Insufficiency, Adrenal Gland Neoplasms

NCT02529306 2018-08-14

BZMC

40 enrolled

Multiple Endocrine Neoplasia Type 1

NCT00188019 2015-07-23

Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers

Phase NA Completed

248 enrolled

Paraganglioma, Pheochromocytoma

NCT01931488 2013-08-29

124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.

Phase 2 Unknown

40 enrolled

Parkinson Disease, Neuroendocrine Tumors

NCT00852501 2013-04-09

Characterization of Receptors in Non-functioning Pituitary Macroadenomas

Pituitary Neoplasms

NCT01373736 2011-06-15

123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors

Phase 3 Unknown

Carcinoid Tumor, Neuroblastoma, Paraganglioma, Pheochromocytoma, Carcinoma, Medullary

NCT00850798 2010-07-26

The Benefits of Intensive Glycemic Control in Elderly Patients With Type 2 Diabetes

208 enrolled

Diabetes Mellitus, Type 2, Multiple Endocrine Neoplasia Type 1

NCT00687778 2008-06-02

11C-Acetate PET/CT Non-FDG-Avid Tumors